CASI Pharmaceuticals (CASIF) Other financing activities (2024)
CASI Pharmaceuticals (CASIF) reported Other financing activities of -$2.0 billion for Q2 2024.
CASI Pharmaceuticals (CASIF) Other financing activities (2024) Analysis & Trends
CASI Pharmaceuticals has reported Other financing activities for 1 years, with the latest figure at -$2.0 billion in Q2 2024.
- For the quarter ending Q2 2024, Other financing activities changed N/A year-over-year to -$2.0 billion; the trailing twelve-month figure through Jun 2024 stood at -$2.0 billion (changed N/A YoY), and the FY2025 full-year result was $681000.0, down 29.06% from the prior year.
- Other financing activities for Q2 2024 stood at -$2.0 billion.
- The five-year high for Other financing activities was -$2.0 billion in Q2 2024, with the low at -$2.0 billion in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 860,679.92 Bn | 860,679.89 Bn | - |
| 2 | Belite Bio | 55,284.00 Bn | 55,284.00 Bn | - |
| 3 | Quantum Biopharma | 16,206.94 Bn | 16,206.93 Bn | - |
| 4 | Legend Biotech | 3,318.00 Bn | 3,317.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,543.84 Bn | 1,543.84 Bn | - |
| 6 | Evaxion A | 1,449.11 Bn | 1,449.09 Bn | - |
| 7 | Psyence Biomedical | 216.99 Bn | 216.98 Bn | - |
| 8 | Vertex Pharmaceuticals | 115.22 Bn | 107.97 Bn | 2.59 Bn |
| 9 | Abivax | 90.58 Bn | 90.58 Bn | - |
| 10 | CASI Pharmaceuticals | - | - | 3.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -2.02 Bn |
| Jun 30, 2024 | -2.02 Bn |